Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging

Copyright © 2021, Ahmad et al..

Regadenoson myocardial perfusion imaging (MPI) is a widely used screening study for patients with an intermediate pretest probability of coronary artery disease (CAD). Via selective agonism of the adenosine A2A receptor, regadenoson can induce coronary steal, revealing stenotic vessel territory through transient ischemia. Common side effects of this medication include chest pain, shortness of breath, nausea, vomiting, atrioventricular block, seizure, and allergic reactions. Here we present a case of severe shivering and chest tightness after the administration of regadenoson, along with a physiologic explanation and treatment.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Cureus - 13(2021), 3 vom: 24. März, Seite e14091

Sprache:

Englisch

Beteiligte Personen:

Ahmad, Tanjeev [VerfasserIn]
Linares, Juan [VerfasserIn]
Valencia, Damian N [VerfasserIn]
Agarwal, Ajay [VerfasserIn]

Links:

Volltext

Themen:

Cardiac stress testing
Case Reports
Drug-related side effects and adverse reactions
Mpi
Myocardial perfusion imaging
Regadenoson
Shivering

Anmerkungen:

Date Revised 02.05.2021

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.7759/cureus.14091

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM324811500